{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T12:55:05Z","timestamp":1789390505626,"version":"build-2803163510"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,3,21]],"date-time":"2017-03-21T00:00:00Z","timestamp":1490054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,3,21]],"date-time":"2017-03-21T00:00:00Z","timestamp":1490054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The Zika virus (ZIKV) outbreak in the Americas and South Pacific poses a significant burden on human health because of ZIKV\u2019s neurotropic effects in the course of fetal development. Vaccine candidates against ZIKV are coming online, but immunological tools to study anti-ZIKV responses in preclinical models, particularly T cell responses, remain sparse. We deployed RNA nanoparticle technology to create a vaccine candidate that elicited ZIKV E protein-specific IgG responses in C57BL\/6 mice as assayed by ELISA. Using this tool, we identified a unique H-2D<jats:sup>b<\/jats:sup>-restricted epitope to which there was a CD8<jats:sup>+<\/jats:sup>T cell response in mice immunized with our modified dendrimer-based RNA nanoparticle vaccine. These results demonstrate that this approach can be used to evaluate new candidate antigens and identify immune correlates without the use of live virus.<\/jats:p>","DOI":"10.1038\/s41598-017-00193-w","type":"journal-article","created":{"date-parts":[[2017,3,15]],"date-time":"2017-03-15T15:08:22Z","timestamp":1489590502000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":156,"title":["An RNA nanoparticle vaccine against Zika virus elicits antibody and CD8+ T cell responses in a mouse model"],"prefix":"10.1038","volume":"7","author":[{"given":"Jasdave S.","family":"Chahal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8129-8635","authenticated-orcid":false,"given":"Tao","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew W.","family":"Woodham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar F.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel G.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidde L.","family":"Ploegh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,21]]},"reference":[{"key":"193_CR1","doi-asserted-by":"publisher","unstructured":"Cao-Lormeau, V.-M. et al. Guillain-Barr\u00e9 Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. The Lancet 387, 1531\u20131539, doi:10.1016\/S0140-6736(16)00562-6 (2016).","DOI":"10.1016\/S0140-6736(16)00562-6"},{"key":"193_CR2","doi-asserted-by":"crossref","unstructured":"Oehler, E. et al. Zika virus infection complicated by Guillain-Barre syndrome\u2013case report, French Polynesia, December 2013. Euro Surveill 19, doi:20720 (2014).","DOI":"10.2807\/1560-7917.ES2014.19.9.20720"},{"key":"193_CR3","doi-asserted-by":"publisher","unstructured":"Brasil, P. et al. Zika Virus Infection in Pregnant Women in Rio de Janeiro \u2014 Preliminary Report. New England Journal of Medicine 375, 2321\u20132334, doi:10.1056\/NEJMoa1602412 (2016).","DOI":"10.1056\/NEJMoa1602412"},{"key":"193_CR4","doi-asserted-by":"publisher","first-page":"e0004517","DOI":"10.1371\/journal.pntd.0004517","volume":"10","author":"M Sarno","year":"2016","unstructured":"Sarno, M. et al. Zika Virus Infection and Stillbirths: A Case of Hydrops Fetalis, Hydranencephaly and Fetal Demise. PLoS Negl Trop Dis 10, e0004517, doi:10.1371\/journal.pntd.0004517 (2016).","journal-title":"PLoS Negl Trop Dis"},{"key":"193_CR5","unstructured":"CDC. Zika virus disease in the United States, 2015\u20132016, http:\/\/www.cdc.gov\/zika\/geo\/united-states.html (2016)."},{"key":"193_CR6","unstructured":"CDC. Advice for people living in or traveling to Wynwood, a neighborhood in Miami, FL, http:\/\/www.cdc.gov\/zika\/intheus\/florida-update.html (2016)."},{"key":"193_CR7","unstructured":"Health, C. o. N. Y. Zika Virus: Travel Alerts, https:\/\/www1.nyc.gov\/site\/doh\/health\/health-topics\/zika-virus.page (2016)."},{"key":"193_CR8","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/nature18952","volume":"536","author":"RA Larocca","year":"2016","unstructured":"Larocca, R. A. et al. Vaccine protection against Zika virus from Brazil. Nature 536, 474\u2013478, doi:10.1038\/nature18952 (2016).","journal-title":"Nature"},{"key":"193_CR9","unstructured":"National Institute of Allergy and Infectious Diseases. Safety and Immunogenicity of a Zika Virus DNA Vaccine, VRC-ZKADNA085-00-VP, in Healthy Adults, https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02840487 (2016)."},{"key":"193_CR10","doi-asserted-by":"crossref","unstructured":"Kwilas, S. et al. A hantavirus pulmonary syndrome (HPS) DNA vaccine delivered using a spring-powered jet injector elicits a potent neutralizing antibody response in rabbits and nonhuman primates. Curr Gene Ther 14, 200\u2013210, doi:CGT-EPUB-60639 (2014).","DOI":"10.2174\/1566523214666140522122633"},{"key":"193_CR11","doi-asserted-by":"publisher","first-page":"e2636","DOI":"10.1371\/journal.pntd.0002636","volume":"8","author":"O Faye","year":"2014","unstructured":"Faye, O. et al. Molecular evolution of Zika virus during its emergence in the 20th century. PLoS Negl Trop Dis 8, e2636, doi:10.1371\/journal.pntd.0002636 (2014).","journal-title":"PLoS Negl Trop Dis"},{"key":"193_CR12","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1590\/0074-02760150192","volume":"110","author":"C Zanluca","year":"2015","unstructured":"Zanluca, C. et al. First report of autochthonous transmission of Zika virus in Brazil. Mem Inst Oswaldo Cruz 110, 569\u2013572, doi:10.1590\/0074-02760150192 (2015).","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"193_CR13","doi-asserted-by":"publisher","first-page":"933","DOI":"10.3201\/eid2205.160065","volume":"22","author":"RS Lanciotti","year":"2016","unstructured":"Lanciotti, R. S., Lambert, A. J., Holodniy, M., Saavedra, S. & Signor Ldel, C. Phylogeny of Zika Virus in Western Hemisphere, 2015. Emerg Infect Dis 22, 933\u2013935, doi:10.3201\/eid2205.160065 (2016).","journal-title":"Emerg Infect Dis"},{"key":"193_CR14","doi-asserted-by":"publisher","first-page":"e1477","DOI":"10.1371\/journal.pntd.0001477","volume":"6","author":"AD Haddow","year":"2012","unstructured":"Haddow, A. D. et al. Genetic characterization of Zika virus strains: geographic expansion of the Asian lineage. PLoS Negl Trop Dis 6, e1477, doi:10.1371\/journal.pntd.0001477 (2012).","journal-title":"PLoS Negl Trop Dis"},{"key":"193_CR15","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1017\/S0022172400025997","volume":"83","author":"AH Fagbami","year":"1979","unstructured":"Fagbami, A. H. Zika virus infections in Nigeria: virological and seroepidemiological investigations in Oyo State. J Hyg (Lond) 83, 213\u2013219 (1979).","journal-title":"J Hyg (Lond)"},{"key":"193_CR16","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/0035-9203(77)90104-3","volume":"71","author":"BG Kirya","year":"1977","unstructured":"Kirya, B. G. & Okia, N. O. A yellow fever epizootic in Zika Forest, Uganda, during 1972: Part 2: Monkey serology. Trans R Soc Trop Med Hyg 71, 300\u2013303 (1977).","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"193_CR17","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/0035-9203(64)90201-9","volume":"58","author":"DI Simpson","year":"1964","unstructured":"Simpson, D. I. Zika Virus Infection in Man. Trans R Soc Trop Med Hyg 58, 335\u2013338 (1964).","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"193_CR18","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1128\/am.22.3.377-379.1971","volume":"22","author":"NE Mettler","year":"1971","unstructured":"Mettler, N. E., Clarke, D. H. & Casals, J. Hemagglutination inhibition with arboviruses: relationship between titers and source of erythrocytes. Appl Microbiol 22, 377\u2013379 (1971).","journal-title":"Appl Microbiol"},{"key":"193_CR19","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1038\/ni.3515","volume":"17","author":"W Dejnirattisai","year":"2016","unstructured":"Dejnirattisai, W. et al. Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus. Nat Immunol 17, 1102\u20131108, doi:10.1038\/ni.3515 (2016).","journal-title":"Nat Immunol"},{"key":"193_CR20","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.chom.2016.03.010","volume":"19","author":"HM Lazear","year":"2016","unstructured":"Lazear, H. M. et al. A Mouse Model of Zika Virus Pathogenesis. Cell Host Microbe 19, 720\u2013730, doi:10.1016\/j.chom.2016.03.010 (2016).","journal-title":"Cell Host Microbe"},{"key":"193_CR21","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.4269\/ajtmh.16-0111","volume":"94","author":"SL Rossi","year":"2016","unstructured":"Rossi, S. L. et al. Characterization of a Novel Murine Model to Study Zika Virus. Am J Trop Med Hyg 94, 1362\u20131369, doi:10.4269\/ajtmh.16-0111 (2016).","journal-title":"Am J Trop Med Hyg"},{"key":"193_CR22","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.cell.2016.05.008","volume":"165","author":"JJ Miner","year":"2016","unstructured":"Miner, J. J. et al. Zika Virus Infection during Pregnancy in Mice Causes Placental Damage and Fetal Demise. Cell 165, 1081\u20131091, doi:10.1016\/j.cell.2016.05.008 (2016).","journal-title":"Cell"},{"key":"193_CR23","doi-asserted-by":"publisher","first-page":"568","DOI":"10.12688\/f1000research.8436.1","volume":"5","author":"AJ Rodriguez-Morales","year":"2016","unstructured":"Rodriguez-Morales, A. J. et al. Mapping Zika virus infection using geographical information systems in Tolima, Colombia, 2015\u20132016. F1000Res 5, 568, doi:10.12688\/f1000research.8436.1 (2016).","journal-title":"F1000Res"},{"key":"193_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/nature18952","author":"RA Larocca","year":"2016","unstructured":"Larocca, R. A. et al. Vaccine protection against Zika virus from Brazil. Nature. doi:10.1038\/nature18952 (2016).","journal-title":"Nature"},{"key":"193_CR25","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.4049\/jimmunol.1402605","volume":"194","author":"MR Bassi","year":"2015","unstructured":"Bassi, M. R. et al. CD8+ T cells complement antibodies in protecting against yellow fever virus. J Immunol 194, 1141\u20131153, doi:10.4049\/jimmunol.1402605 (2015).","journal-title":"J Immunol"},{"key":"193_CR26","doi-asserted-by":"publisher","first-page":"411","DOI":"10.2217\/fmb.13.171","volume":"9","author":"A Mathew","year":"2014","unstructured":"Mathew, A., Townsley, E. & Ennis, F. A. Elucidating the role of T cells in protection against and pathogenesis of dengue virus infections. Future Microbiol 9, 411\u2013425, doi:10.2217\/fmb.13.171 (2014).","journal-title":"Future Microbiol"},{"key":"193_CR27","doi-asserted-by":"publisher","first-page":"8312","DOI":"10.1128\/JVI.78.15.8312-8321.2004","volume":"78","author":"B Shrestha","year":"2004","unstructured":"Shrestha, B. & Diamond, M. S. Role of CD8+ T cells in control of West Nile virus infection. J Virol 78, 8312\u20138321, doi:10.1128\/JVI.78.15.8312-8321.2004 (2004).","journal-title":"J Virol"},{"key":"193_CR28","doi-asserted-by":"publisher","first-page":"E4133","DOI":"10.1073\/pnas.1600299113","volume":"113","author":"JS Chahal","year":"2016","unstructured":"Chahal, J. S. et al. Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single dose. Proc Natl Acad Sci USA 113, E4133\u20134142, doi:10.1073\/pnas.1600299113 (2016).","journal-title":"Proc Natl Acad Sci USA"},{"key":"193_CR29","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S0140-6736(16)00003-9","volume":"387","author":"A Enfissi","year":"2016","unstructured":"Enfissi, A., Codrington, J., Roosblad, J., Kazanji, M. & Rousset, D. Zika virus genome from the Americas. Lancet 387, 227\u2013228, doi:10.1016\/S0140-6736(16)00003-9 (2016).","journal-title":"Lancet"},{"key":"193_CR30","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1083\/jcb.107.6.2075","volume":"107","author":"S Froshauer","year":"1988","unstructured":"Froshauer, S., Kartenbeck, J. & Helenius, A. Alphavirus Rna Replicase Is Located on the Cytoplasmic Surface of Endosomes and Lysosomes. J Cell Biol 107, 2075\u20132086, doi:10.1083\/jcb.107.6.2075 (1988).","journal-title":"J Cell Biol"},{"key":"193_CR31","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1080\/08830180490265529","volume":"23","author":"ML Li","year":"2004","unstructured":"Li, M. L. & Stollar, V. Alphaviruses and apoptosis. International reviews of immunology 23, 7\u201324 (2004).","journal-title":"International reviews of immunology"},{"key":"193_CR32","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/j.1749-6632.2001.tb02703.x","volume":"951","author":"GJ Chang","year":"2001","unstructured":"Chang, G. J., Davis, B. S., Hunt, A. R., Holmes, D. A. & Kuno, G. Flavivirus DNA vaccines: current status and potential. Annals of the New York Academy of Sciences 951, 272\u2013285 (2001).","journal-title":"Annals of the New York Academy of Sciences"},{"key":"193_CR33","doi-asserted-by":"publisher","first-page":"621","DOI":"10.2217\/fvl.09.56","volume":"4","author":"JE Lee","year":"2009","unstructured":"Lee, J. E. & Saphire, E. O. Ebolavirus glycoprotein structure and mechanism of entry. Future Virol 4, 621\u2013635, doi:10.2217\/fvl.09.56 (2009).","journal-title":"Future Virol"},{"key":"193_CR34","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/375291a0","volume":"375","author":"FA Rey","year":"1995","unstructured":"Rey, F. A., Heinz, F. X., Mandl, C., Kunz, C. & Harrison, S. C. The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature 375, 291\u2013298, doi:10.1038\/375291a0 (1995).","journal-title":"Nature"},{"key":"193_CR35","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nature02165","volume":"427","author":"Y Modis","year":"2004","unstructured":"Modis, Y., Ogata, S., Clements, D. & Harrison, S. C. Structure of the dengue virus envelope protein after membrane fusion. Nature 427, 313\u2013319, doi:10.1038\/nature02165 (2004).","journal-title":"Nature"},{"key":"193_CR36","doi-asserted-by":"crossref","unstructured":"Nybakken, G. E. et al. Structural basis of West Nile virus neutralization by a therapeutic antibody. Nature 437, 764\u2013769, doi:nature03956 (2005).","DOI":"10.1038\/nature03956"},{"key":"193_CR37","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1110\/ps.0239403","volume":"12","author":"M Nielsen","year":"2003","unstructured":"Nielsen, M. et al. Reliable prediction of T-cell epitopes using neural networks with novel sequence representations. Protein Sci 12, 1007\u20131017, doi:10.1110\/ps.0239403 (2003).","journal-title":"Protein Sci"},{"key":"193_CR38","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkn202","volume":"36","author":"C Lundegaard","year":"2008","unstructured":"Lundegaard, C. et al. NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8\u201311. Nucleic Acids Res 36, W509\u2013512, doi:10.1093\/nar\/gkn202 (2008).","journal-title":"Nucleic Acids Res"},{"key":"193_CR39","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/cbic.201300796","volume":"15","author":"MD Simon","year":"2014","unstructured":"Simon, M. D. et al. Rapid flow-based peptide synthesis. Chembiochem 15, 713\u2013720, doi:10.1002\/cbic.201300796 (2014).","journal-title":"Chembiochem"},{"key":"193_CR40","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/0092-8674(90)90020-F","volume":"62","author":"TN Schumacher","year":"1990","unstructured":"Schumacher, T. N. et al. Direct binding of peptide to empty MHC class I molecules on intact cells and in vitro. Cell 62, 563\u2013567. doi:0092-8674(90)90020-F (1990).","journal-title":"Cell"},{"key":"193_CR41","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1002\/eji.1830230929","volume":"23","author":"MC Feltkamp","year":"1993","unstructured":"Feltkamp, M. C. et al. Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells. Eur J Immunol 23, 2242\u20132249, doi:10.1002\/eji.1830230929 (1993).","journal-title":"Eur J Immunol"},{"key":"193_CR42","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.4049\/jimmunol.150.4.1212","volume":"150","author":"GB Lipford","year":"1993","unstructured":"Lipford, G. B., Hoffman, M., Wagner, H. & Heeg, K. Primary in vivo responses to ovalbumin. Probing the predictive value of the Kb binding motif. J Immunol 150, 1212\u20131222 (1993).","journal-title":"J Immunol"},{"key":"193_CR43","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1073\/pnas.88.6.2283","volume":"88","author":"WM Kast","year":"1991","unstructured":"Kast, W. M. et al. Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide. Proc Natl Acad Sci USA 88, 2283\u20132287 (1991).","journal-title":"Proc Natl Acad Sci USA"},{"key":"193_CR44","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1128\/jvi.54.1.53-57.1985","volume":"54","author":"MN Al-Ahdal","year":"1985","unstructured":"Al-Ahdal, M. N., Nakamura, I. & Flanagan, T. D. Cytotoxic T-lymphocyte reactivity with individual Sendai virus glycoproteins. J Virol 54, 53\u201357 (1985).","journal-title":"J Virol"},{"key":"193_CR45","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1002\/eji.1830220638","volume":"22","author":"K Deres","year":"1992","unstructured":"Deres, K. et al. Preferred size of peptides that bind to H-2 Kb is sequence dependent. Eur J Immunol 22, 1603\u20131608, doi:10.1002\/eji.1830220638 (1992).","journal-title":"Eur J Immunol"},{"key":"193_CR46","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.4049\/jimmunol.130.3.1090","volume":"130","author":"LP de Waal","year":"1983","unstructured":"de Waal, L. P., Kast, W. M., Melvold, R. W. & Melief, C. J. Regulation of the cytotoxic T lymphocyte response against Sendai virus analyzed with H-2 mutants. J Immunol 130, 1090\u20131096 (1983).","journal-title":"J Immunol"},{"key":"193_CR47","doi-asserted-by":"crossref","unstructured":"Rudolph, M. G. et al. The crystal structures of K(bm1) and K(bm8) reveal that subtle changes in the peptide environment impact thermostability and alloreactivity. Immunity 14, 231\u2013242, doi:S1074-7613(01)00105-4 (2001).","DOI":"10.1016\/S1074-7613(01)00105-4"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-00193-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-00193-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-00193-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T17:02:38Z","timestamp":1692723758000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-00193-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,21]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["193"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-00193-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,21]]},"assertion":[{"value":"27 October 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"O.F.K., J.S.C., H.L.P., and D.G.A. have filed a patent on the MDNP-based vaccine platform.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"252"}}